Ingevity (NGVT)
(Delayed Data from NYSE)
$38.44 USD
+1.94 (5.32%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $38.46 +0.02 (0.05%) 7:58 PM ET
5-Strong Sell of 5 5
C Value D Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$38.44 USD
+1.94 (5.32%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $38.46 +0.02 (0.05%) 7:58 PM ET
5-Strong Sell of 5 5
C Value D Growth C Momentum D VGM
Zacks News
Ingevity's (NGVT) Earnings and Revenues Lag Estimates in Q1
by Zacks Equity Research
A slower recovery in automotive in China and continued destocking weigh on Ingevity's (NGVT) Q1 results.
Ingevity (NGVT) Q1 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Ingevity (NGVT) delivered earnings and revenue surprises of -13.49% and 4.30%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Green Plains Renewable Energy (GPRE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Green Plains (GPRE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Ingevity (NGVT) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Ingevity (NGVT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why You Should Keep Ingevity (NGVT) Stock in Your Portfolio
by Zacks Equity Research
Ingevity (NGVT) gains on solid demand and higher selling prices in its Performance Chemicals segment, actions to drive long-term growth and price hike measures to mitigate cost inflation.
Ingevity (NGVT) Benefits From Strong Demand and Growth Actions
by Zacks Equity Research
Ingevity (NGVT) gains on strength in its engineered polymers and industrial specialties businesses and actions to drive growth amid costs-related headwinds.
Ingevity (NGVT) Down 16.8% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Ingevity (NGVT) to Feature Capa at European Coatings Show
by Zacks Equity Research
Ingevity (NGVT) will showcase the benefits of using Capa technology and AltaVeg FA 120 at the European Coatings Show 2023.
Ingevity's (NGVT) Earnings and Revenues Miss Estimates in Q4
by Zacks Equity Research
Ingevity (NGVT) gains from higher pricing across its business amid headwinds from higher levels of consumer destocking weighing on its performance in Q4.
Ingevity (NGVT) Lags Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Ingevity (NGVT) delivered earnings and revenue surprises of -36.67% and 0.38%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Ingevity (NGVT) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Ingevity (NGVT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Axalta Coating Systems (AXTA) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Axalta Coating Systems (AXTA) delivered earnings and revenue surprises of 5.56% and 1.65%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Ingevity (NGVT) Gains on Demand Strength and Growth Actions
by Zacks Equity Research
Ingevity (NGVT) benefits from strength in its engineered polymers and industrial specialties businesses and actions to drive growth amid costs-related headwinds.
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Ingevity (NGVT) Up 9.9% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Ingevity (NGVT) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks Industry Outlook Highlights Ashland, Livent, Ingevity and Flexible Solutions International
by Zacks Equity Research
Ashland, Livent, Ingevity and Flexible Solutions International are part of the Zacks Industry Outlook article.
4 Chemical Specialty Stocks to Escape Industry Challenges
by Anindya Barman
Slowing end-market demand and input cost pressure dampen prospects for the Zacks Chemicals Specialty industry. ASH, LTHM, NGVT and FSI are set to gain from self-help actions.
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Are Basic Materials Stocks Lagging Glencore (GLNCY) This Year?
by Zacks Equity Research
Here is how Glencore PLC (GLNCY) and Ingevity (NGVT) have performed compared to their sector so far this year.
Ingevity's (NGVT) Earnings and Sales Top Estimates in Q3
by Zacks Equity Research
Ingevity (NGVT) benefits from strong demand and actions to increase prices in the third quarter.
How Much Upside is Left in Ingevity (NGVT)? Wall Street Analysts Think 30%
by Zacks Equity Research
The mean of analysts' price targets for Ingevity (NGVT) points to a 30% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Ingevity (NGVT) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Ingevity (NGVT) delivered earnings and revenue surprises of 21.51% and 12.51%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Ingevity (NGVT) Wraps Up Expansion of Polyols Production
by Zacks Equity Research
The expansion at Ingevity's (NGVT) plant in DeRidder increases its global capacity for producing polyols by 40%.
Ingevity (NGVT) is a Top-Ranked Growth Stock: Should You Buy?
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.